AstraZeneca (AZN) Event May 20, 2022, 15:26 UTC 8 1 comments (99% Neutral) AstraZeneca (AZN) Files Form 6-K Comment Full text
TherapeuticsMD Inc (TXMD) Event May 20, 2022, 14:30 UTC 9 1 comments (99% Positive) TherapeuticsMD, Inc. (TXMD) Announces Clinical Development Update Comment Full text
Krystal Biotech (KRYS) Event May 20, 2022, 12:26 UTC 9 1 comments (99% Neutral) KRYSTAL BIOTECH, INC. (KRYS) Announces Enrollment Update for tropism Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX) Event May 20, 2022, 12:15 UTC 9 1 comments (99% Neutral) CORTEXYME, INC. (CRTX) Announces Executive Departure Comment Full text
Sesen Bio Inc (merger with a company Carisma Therapeutics Inc (NASDAQ:CARM)) (SESN) Event May 20, 2022, 12:00 UTC 10 1 comments (19% Negative) SESEN BIO, INC. (SESN) Announces Regulatory Update Comment Full text
Amarin Corporation Plc (AMRN) Event May 20, 2022, 11:47 UTC 9 1 comments (99% Neutral) AMARIN CORP PLC\UK (AMRN) Announces Business Combination Comment Full text
Y-mAbs Therapeutics Inc (YMAB) Event May 19, 2022, 20:35 UTC 9 1 comments (99% Neutral) Y-MABS THERAPEUTICS, INC. (YMAB) Announces New Board Appointment Comment Full text
Personalis Inc (PSNL) Event May 19, 2022, 20:30 UTC 9 1 comments (99% Neutral) Personalis, Inc. (PSNL) Announces Regulatory Update Comment Full text
Atara Biotherapeutics Inc (ATRA) Event May 19, 2022, 20:05 UTC 9 1 comments (19% Negative) Atara Biotherapeutics, Inc. (ATRA) Announces Clinical Trial Timeline Adjustment Comment Full text
Replimune Group Inc (REPL) Event May 19, 2022, 12:10 UTC 10 1 comments (75% Positive) REPLIMUNE GROUP, INC. (REPL) Announces Enrollment Update for results Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text